Caribou Biosciences, Inc. (CRBU) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts CRBU Hot Sheet
Join SI Premium – FREE
Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q1 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.39 million versus the consensus estimate of $2.65 million.
For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- First Resource Bank (FRSB) Tops Q2 EPS by 92c
- C&F Financial (CFFI) Tops Q4 EPS by 240c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
